Literature DB >> 19877362

[Recommendations for clinical practice. Osteo-articular infection therapy according to materials used (prosthesis, implants, osteosynthesis)].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19877362     DOI： 10.1016/j.medmal.2009.05.003

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN： 0399-077X            Impact factor:   2.152


× No keyword cloud information.
  11 in total

1.  Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid.

Authors:  Amélie Marsot; Amelie Ménard; Julien Dupouey; Cedric Muziotti; Romain Guilhaumou; Olivier Blin
Journal:  Br J Clin Pharmacol       Date:  2017-01-16       Impact factor: 4.335

2.  Influence of daily dosage and frequency of administration of rifampicin-levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections.

Authors:  S Nguyen; O Robineau; M Titecat; N Blondiaux; M Valette; C Loiez; E Beltrand; H Migaud; E Senneville
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-19       Impact factor: 3.267

3.  Clinical spectrum and outcome of critically ill patients suffering from prosthetic joint infections.

Authors:  Y Maaloum; A Meybeck; D Olive; N Boussekey; P-Y Delannoy; A Chiche; H Georges; E Beltrand; E Senneville; T d'Escrivan; O Leroy
Journal:  Infection       Date:  2012-10-25       Impact factor: 3.553

4.  MALDI-TOF MS performance compared to direct examination, culture, and 16S rDNA PCR for the rapid diagnosis of bone and joint infections.

Authors:  E Lallemand; G Coiffier; C Arvieux; E Brillet; P Guggenbuhl; A Jolivet-Gougeon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-04       Impact factor: 3.267

5.  Evaluation of current dosing guidance for oral rifampicin treatment in adult patients with osteoarticular infections.

Authors:  Amélie Marsot; Amélie Ménard; Julien Dupouey; Laurent Allanioux; Olivier Blin; Romain Guilhaumou
Journal:  Br J Clin Pharmacol       Date:  2020-05-13       Impact factor: 4.335

6.  Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus.

Authors:  Florent Valour; Judith Karsenty; Anissa Bouaziz; Florence Ader; Michel Tod; Sébastien Lustig; Frédéric Laurent; René Ecochard; Christian Chidiac; Tristan Ferry
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

7.  Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations.

Authors:  E Fiaux; M Titecat; O Robineau; J Lora-Tamayo; Y El Samad; M Etienne; N Frebourg; N Blondiaux; B Brunschweiler; F Dujardin; E Beltrand; C Loiez; V Cattoir; J P Canarelli; C Hulet; M Valette; S Nguyen; F Caron; H Migaud; E Senneville
Journal:  BMC Infect Dis       Date:  2016-10-13       Impact factor: 3.090

8.  Bacteriological aspects of chronic osteoarticular infections in adults: the influence of the osteosynthesis material.

Authors:  Adil Maleb; Mohammed Frikh; Yassine Ben Lahlou; Belkacem Chagar; Abdelhay Lemnouer; Mostafa Elouennass
Journal:  BMC Res Notes       Date:  2017-11-28

9.  Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France.

Authors:  M Tonnelier; A Bouras; C Joseph; Y El Samad; B Brunschweiler; J-L Schmit; C Mabille; J-P Lanoix
Journal:  BMC Infect Dis       Date:  2021-02-12       Impact factor: 3.090

10.  Therapeutic outcome of spinal implant infections caused by Staphylococcus aureus: A retrospective observational study.

Authors:  Oh-Hyun Cho; In-Gyu Bae; Song Mi Moon; Seong Yeon Park; Yee Gyung Kwak; Baek-Nam Kim; Shi Nae Yu; Min Hyok Jeon; Tark Kim; Eun Ju Choo; Eun Jung Lee; Tae Hyong Kim; Seong-Ho Choi; Jin-Won Chung; Kyung-Chung Kang; Jung Hee Lee; Yu-Mi Lee; Mi Suk Lee; Ki-Ho Park
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.